![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euroapi-corp-ad-w30-desktop-header-1-2gif-57087.gif)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euro-api-mob-header-w30gif-19381.gif)
20
Xinjiang Nuziline Bio-pharmaceutical Co., Ltd. Tuergen Cn, based in China, is a pharmaceutical company.
One of their significant offerings is Estrogens, conjugated, 3.00% in lactose monohydrate, supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 2010-153 - Rev 00
This Chemical Type CEP, issued on February 19, 2018, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 1512 associated with this CEP further emphasizes